K. Scott Baker

8.5k total citations · 1 hit paper
162 papers, 4.7k citations indexed

About

K. Scott Baker is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, K. Scott Baker has authored 162 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 51 papers in Public Health, Environmental and Occupational Health and 47 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in K. Scott Baker's work include Hematopoietic Stem Cell Transplantation (51 papers), Acute Lymphoblastic Leukemia research (25 papers) and Global Maternal and Child Health (21 papers). K. Scott Baker is often cited by papers focused on Hematopoietic Stem Cell Transplantation (51 papers), Acute Lymphoblastic Leukemia research (25 papers) and Global Maternal and Child Health (21 papers). K. Scott Baker collaborates with scholars based in United States, United Kingdom and Sweden. K. Scott Baker's co-authors include John E. Wagner, Daniel J. Weisdorf, Paul J. Orchard, Todd E. DeFor, Margaret L. MacMillan, James G. Gurney, Stella M. Davies, Bruce R. Blazar, Charles Peters and Kirsten K. Ness and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

K. Scott Baker

149 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

2002 743 citations John E. Wagner, Todd E. DeFor et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Scott Baker United States	40	2.3k	1.0k	1.0k	920	893	162	4.7k
Joseph Pidala United States	39	3.5k 1.5×	1.2k 1.2×	871 0.9×	1.1k 1.2×	433 0.5×	170	5.0k
Raymond J. Hutchinson United States	42	1.6k 0.7×	1.9k 1.9×	1.5k 1.5×	1.3k 1.4×	822 0.9×	136	5.6k
Hans A. Messner Canada	42	3.1k 1.4×	819 0.8×	458 0.5×	1.3k 1.4×	513 0.6×	221	5.7k
Steven Z. Pavletic United States	45	4.8k 2.1×	1.3k 1.3×	820 0.8×	1.4k 1.5×	907 1.0×	267	7.0k
Kathleen A. Sobocinski United States	28	2.9k 1.3×	1.1k 1.1×	915 0.9×	2.0k 2.2×	510 0.6×	38	5.4k
Edward A. Copelan United States	31	3.9k 1.7×	1.3k 1.3×	658 0.7×	1.4k 1.6×	287 0.3×	194	5.7k
Sheila Weitzman Canada	46	1.8k 0.8×	735 0.7×	878 0.9×	1.3k 1.4×	841 0.9×	171	7.4k
Howard J. Weinstein United States	43	2.2k 1.0×	1.6k 1.6×	736 0.7×	1.2k 1.4×	794 0.9×	122	5.4k
Madan Jagasia United States	43	5.1k 2.2×	1.6k 1.5×	755 0.7×	1.6k 1.8×	576 0.6×	251	7.2k
Christina Peters Austria	48	4.1k 1.8×	2.2k 2.1×	1.4k 1.4×	2.1k 2.3×	778 0.9×	242	8.2k

Countries citing papers authored by K. Scott Baker

Since Specialization

Citations

This map shows the geographic impact of K. Scott Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Scott Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Scott Baker more than expected).

Fields of papers citing papers by K. Scott Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Scott Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Scott Baker. The network helps show where K. Scott Baker may publish in the future.

Co-authorship network of co-authors of K. Scott Baker

This figure shows the co-authorship network connecting the top 25 collaborators of K. Scott Baker. A scholar is included among the top collaborators of K. Scott Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Scott Baker. K. Scott Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosenberg, Abby R., Kaitlyn Fladeboe, Chuan Zhou, et al.. (2025). Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced Cancer. JCO Oncology Practice. 22(2). 243–254.

Shinozawa, Tadahiro, Kazumasa Miyamoto, K. Scott Baker, et al.. (2025). TAK-994 mechanistic investigation into drug-induced liver injury. Toxicological Sciences. 204(2). 143–153. 2 indexed citations

Baker, K. Scott, Pedro Aíde, Craig Bonnington, et al.. (2025). Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique. Malaria Journal. 24(1). 56–56. 1 indexed citations

Rotimi, Kunle, et al.. (2024). Urban–rural differences in seasonal malaria chemoprevention coverage and characteristics of target populations in nine states of Nigeria: a comparative cross-sectional study. Malaria Journal. 23(1). 4–4. 3 indexed citations

Rotz, Seth J., Lori Wiener, K. Scott Baker, et al.. (2024). Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes. Transplantation and Cellular Therapy. 31(4). 224.e1–224.e13.

Chestnutt, Elisabeth G., Laura Donovan, Helen Counihan, et al.. (2024). Exploring existing malaria services and the feasibility of implementing community engagement approaches amongst conflict-affected communities in Cameroon: a qualitative study. Malaria Journal. 23(1). 155–155.

Rotimi, Kunle, et al.. (2024). Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria. Malaria Journal. 23(1). 91–91. 1 indexed citations

Taylor, Mallory, Steve W. Cole, Ruta Brazauskas, et al.. (2023). Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis. Blood Advances. 7(22). 6830–6838. 5 indexed citations

Smith, Helen, et al.. (2023). Optimizing the role of ‘lead mothers’ in seasonal malaria chemoprevention (SMC) campaigns: formative research in Kano State, northern Nigeria. Malaria Journal. 22(1). 13–13. 5 indexed citations

10.

Nnaji, Chukwudi A, Patrick Walker, Gina Cuomo-Dannenburg, et al.. (2023). Rapid assessments for the deployment of seasonal malaria chemoprevention in new geographies of east and southern Africa: protocol for a hybrid type II implementation study. (Preprint). JMIR Research Protocols. 1 indexed citations

11.

Baker, K. Scott, Pedro Aíde, Craig Bonnington, et al.. (2022). Feasibility, Acceptability, and Protective Efficacy of Seasonal Malaria Chemoprevention Implementation in Nampula Province, Mozambique: Protocol for a Hybrid Effectiveness-Implementation Study. JMIR Research Protocols. 11(9). e36403–e36403. 5 indexed citations

12.

Ward, Charlotte, et al.. (2021). Health management information system (HMIS) data quality and associated factors in Massaguet district, Chad. BMC Medical Informatics and Decision Making. 21(1). 326–326. 14 indexed citations

13.

Anixt, Julia S., Pamela J. Goodman, Katherine Bowers, et al.. (2020). Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report. JNCI Journal of the National Cancer Institute. 113(4). 481–495. 20 indexed citations

14.

Baker, K. Scott, Charlotte Ward, Helen Smith, et al.. (2020). Usability and acceptability of a multimodal respiratory rate and pulse oximeter device in case management of children with symptoms of pneumonia: A cross‐sectional study in Ethiopia. Acta Paediatrica. 110(5). 1620–1632. 10 indexed citations

15.

Baker, K. Scott, et al.. (2019). Automated Respiratory Rate Counter to Assess Children for Symptoms of Pneumonia: Protocol for Cross-Sectional Usability and Acceptability Studies in Ethiopia and Nepal. JMIR Research Protocols. 9(3). e14405–e14405. 9 indexed citations

16.

Petryk, Anna, Lei Zhang, Todd E. DeFor, et al.. (2016). Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(8). 1487–1492. 15 indexed citations

17.

Tarlock, Katherine, et al.. (2014). Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long‐term voriconazole. Pediatric Blood & Cancer. 62(5). 918–920. 11 indexed citations

18.

McCune, Jeannine S., Meagan J. Bemer, Jeffrey S. Barrett, et al.. (2013). Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization. Clinical Cancer Research. 20(3). 754–763. 110 indexed citations

19.

Smith, Angela R., Thomas G. Gross, & K. Scott Baker. (2009). Transplant Outcomes for Primary Immunodeficiency Disease. Seminars in Hematology. 47(1). 79–85. 11 indexed citations

20.

Kharbanda, Sandhya, Angela Panoskaltsis‐Mortari, Imad Y. Haddad, et al.. (2006). Inflammatory Cytokines and the Development of Pulmonary Complications after Allogeneic Hematopoietic Cell Transplantation in Patients with Inherited Metabolic Storage Disorders. Biology of Blood and Marrow Transplantation. 12(4). 430–437. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact